Skip to main content

A Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects with IgA Nephropathy on Sodium-glucose Cotransporter-2 Inhibitors (SGLT2i)

Open
  • Protocol code: CHK01-03
  • EudraCT code: No aplica
  • Research group: Nephrology and kidney transplantation
  • Service: Nephrology
  • Principal investigator:  Soler Romeo, Maria Jose
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Phase: Fase II